Bronchoplasty in Korea

At a Glance

Overview

Bronchoplasty is a surgical procedure in which a damaged, stenotic, or tumour-affected segment of a bronchus — the major airway branches of the lungs — is resected and the remaining healthy ends are rejoined (anastomosed).

The goal is to restore open, functional airflow while sparing as much lung parenchyma as possible.

The most common form is sleeve resection, in which a circumferential ring of the central or lobar bronchus is removed along with the affected lobe. The upper bronchial stump is then sutured directly to the lower bronchial stump, avoiding the need for a full pneumonectomy (total lung removal).

Candidates include patients with non-small cell lung cancer (NSCLC) involving a main or lobar bronchus, benign bronchial stenosis (often post-tuberculosis or post-transplant), low-grade airway neoplasms, or traumatic bronchial injury. The lung-sparing approach is strongly preferred over pneumonectomy when the disease extent allows it.

Minimally invasive approaches — video-assisted thoracoscopic surgery (VATS) and robot-assisted thoracic surgery (RATS) — have become the dominant techniques at high-volume Korean thoracic centres. A 3D imaging system is now commonly used during VATS sleeve resection to improve precision of the anastomosis.

Bronchoplasty is a technically demanding procedure requiring a surgeon with dedicated thoracic oncology training. Case volume at the operating institution correlates strongly with anastomotic integrity and complication rates — a factor that makes centre selection critical for international patients.

Am I a Candidate?

You may be a candidate for bronchoplasty if:

• You have non-small cell lung cancer (NSCLC) with endobronchial or peribronchial involvement of a lobar or segmental bronchus
• You have a benign bronchial stricture — such as post-tuberculosis stenosis, post-lung-transplant anastomotic narrowing, or granulomatous disease
• You have a low-grade airway tumour (e.g. carcinoid, mucoepidermoid carcinoma) accessible via bronchial resection
• Your pulmonary function tests indicate you would tolerate lobectomy but NOT pneumonectomy — making lobe-sparing sleeve resection the safer choice
• You have a post-intubation or traumatic bronchial injury with significant stricture formation

You are generally NOT a candidate if:

• Disease has spread extensively beyond the bronchus into surrounding vascular structures in a way that prevents safe anastomosis
• Your overall cardiopulmonary reserve is too low to tolerate general anaesthesia and single-lung ventilation
• Active systemic infection is present
• You have had prior high-dose radiation to the planned anastomotic site (relative contraindication; assessed case-by-case)

Pre-operative assessment in Korea typically includes high-resolution CT, bronchoscopy, PET-CT (for oncology cases), pulmonary function testing (spirometry + DLCO), and cardiac evaluation.

How the Procedure Works

Pre-operative preparation

The patient undergoes bronchoscopy to map the exact extent of bronchial disease and plan the resection margins. A mediastinal staging workup is completed for oncology cases. A double-lumen endotracheal tube or bronchial blocker is placed to allow single-lung ventilation during the operation.

Surgical approach

Most Korean thoracic centres now perform bronchoplasty via VATS (video-assisted thoracoscopic surgery) or robotic assistance rather than open thoracotomy. The patient is positioned in lateral decubitus. Two to four small port incisions are made; a utility incision of 3–5 cm is used for specimen extraction.

Resection

The inferior pulmonary ligament is divided to reduce tension on the eventual anastomosis. The surgical team dissects the affected bronchial segment free from surrounding pulmonary artery and lymphatic tissue. The bronchus is divided at clean margins (confirmed by frozen-section pathology in oncology cases).

The lobe containing the diseased segment is removed.

Anastomosis

The two bronchial stumps are reapproximated using interrupted or continuous absorbable sutures. A water-submersion pneumostasis test — inflating the lung to approximately 20 cm H₂O pressure under saline — confirms no air leak.

A pericardial fat pad or intercostal muscle flap may be wrapped around the anastomosis to reinforce it and protect the nearby pulmonary artery.

Closure and drain placement

One or two chest drains are placed. The port sites are closed in layers. The patient is extubated in the operating room if haemodynamically stable.

Total operative time ranges from approximately 2.5 to 4 hours; anastomosis construction alone takes 18–76 minutes depending on complexity and approach.

Recovery Timeline

Days 1–3 (ICU or high-dependency unit)

• Continuous oxygen monitoring and pulmonary physiotherapy begin immediately
• Incentive spirometry and early mobilisation (sitting, then standing) initiated within 24 hours
• Chest drains remain in place; output and air leak assessed daily

Days 4–7 (ward)

• Chest drains removed when output is low and no air leak is detected
• Pain managed with epidural or patient-controlled analgesia, transitioning to oral medications
• Physiotherapy includes breathing exercises, gentle walking circuits
• Bronchoscopy may be performed at day 5–7 to inspect anastomotic healing

Days 7–12 (pre-discharge)

• Most patients are discharged at 7–12 days; complex cases with minor complications may extend to 14 days
• Discharge criteria: no air leak, oxygen saturation acceptable on room air, adequate oral intake, controlled pain
• International patients remain in Korea and attend outpatient follow-up visits

Weeks 2–6 (outpatient, in Korea)

• Follow-up bronchoscopy at 2–3 weeks assesses anastomotic patency
• Driving and lifting restrictions remain in effect
• Gradual return to light activities; no strenuous exertion
• Fit-to-fly assessment typically occurs at week 4–6; medical clearance is required before boarding a long-haul flight

Months 2–4 (home country)

• Pulmonary function testing repeated to document recovery
• CT chest imaging at 3 months (oncology cases)
• Full activity generally restored by month 3–4 for straightforward sleeve resections

Cost Breakdown

Korea does not publish a single national tariff for bronchoplasty, and costs vary by hospital tier, anaesthesia duration, ICU use, and whether the case is oncological or non-oncological. The ranges below are representative approximations based on available international patient-facing data from Korean medical tourism sources.

Surgeon and anaesthesia fees form the largest single component, followed by operating room and equipment costs, then ward stay.

For context: comparable thoracic sleeve resection in the United States typically falls in the $40,000–$80,000+ range (hospital bill alone, before insurance), and in Western Europe the all-in private cost commonly exceeds $25,000–$45,000. Korea's combination of high surgical volume, lower overhead, and government-backed medical tourism infrastructure positions it competitively.

All major KHIDI-registered Korean hospitals issue itemised cost estimates for international patients before admission. The International Patient Center at each facility handles currency conversion, payment scheduling, and insurance liaison.

Korea's Medical Tourism Visa (Medical Care Visa, C-3-3 or G-1-10) covers the patient and one accompanying guardian for the duration of treatment plus recovery — a significant logistical advantage over countries that limit medical visa durations.

Why Korea

South Korea has built one of Asia's most concentrated thoracic surgery ecosystems over the past two decades.

Lung cancer is the leading cause of cancer death in Korea, which has driven exceptionally high operative volumes at major teaching hospitals — high volume correlates with better outcomes for technically demanding procedures like sleeve resection.

Korea's Ministry of Food and Drug Safety (MFDS) and the Korea Health Industry Development Institute (KHIDI) jointly oversee foreign-patient medical institutions through the KAHF (Korean Accreditation for Healthcare serving Foreign patients) system. Only registered institutions may legally treat international patients, providing a regulatory layer absent in many competing destinations.

The Medical Korea programme — administered under the Ministry of Health and Welfare — connects international patients with accredited hospitals, offers interpreter services, and provides a patient ombudsman channel for dispute resolution.

Minimally invasive thoracic surgery adoption in Korea is high. VATS and robotic sleeve bronchoplasty are now routine at leading centres, reducing open-chest procedures, shortening hospital stays, and lowering complication rates compared with traditional thoracotomy.

Korea's National Health Insurance system sets procedure fee structures that indirectly anchor what hospitals charge international patients, preventing the extreme price inflation seen in purely private markets.

Seoul's Gangnam medical district and major university hospital campuses offer English-language international patient coordinators, dedicated wards for foreign patients, and logistics support including hotel partnerships near hospital campuses — reducing the organisational burden on patients travelling alone or with one accompanying guardian.

Related Topics

Sources

• VATS sleeve resection and bronchoplasty using 3D imaging — PMC
• Bronchoplasty using continuous suture in thoracoscopic sleeve lobectomy — PMC
• Medical Korea — official foreign patient information portal

Top Hospitals